Denali Therapeutics Insider Trades
NASDAQ: DNLIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 7 · $1.30M
- Shares bought / sold
- 0 / 71.13K
- Net activity
- Net selling $1.3 million
Denali Therapeutics insider activity
Over the last 12 months, Denali Therapeutics insiders reported 20 transactions on SEC Form 4: 0 open-market purchases and 7 sales. Insiders bought $0 and sold $1.3 million worth of stock, for net insider selling of $1.3 million. The largest seller was Watts Ryan J., with $580,767 in reported sales.
The most recent filing shows Chin Peter Scott (Chief Medical Officer) selling 1,654 shares at $22.29 on Sep 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DNLI's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
DNLI insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 4, 2026 | Chin Peter ScottChief Medical Officer | Sale | 1,654 | $36.87K | Form 4 |
| Sep 2, 2026 | Thornberry NancyDirector | Sale | 615 | $14.60K | Form 4 |
| Sep 2, 2026 | Thornberry NancyDirector | Sale | 10,824 | $247.33K | Form 4 |
| Sep 1, 2026 | Schuth Alexander O.COFO and Secretary | Sale | 2,768 | $64.88K | Form 4 |
| Aug 12, 2026 | Watts Ryan J.President and CEO | Gift | 32,220 | — | Form 4 |
| Aug 11, 2026 | Schuth Alexander O.COFO and Secretary | Sale | 2,857 | $71.62K | Form 4 |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | Cook Jennifer E.Director | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | Van Hauwermeiren TimothyDirector | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | Thornberry NancyDirector | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | Schenkein David PDirector | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | Klein Peter SDirector | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | Krognes Steve E.Director | Award | 6,408 | — | Form 4 |
| Jun 3, 2026 | FLATLEY JAY TDirector | Award | 6,408 | — | Form 4 |
| Jan 6, 2026 | Watts Ryan J.President and CEO | Sale | 35,198 | $580.77K | Form 4 |
| Jan 6, 2026 | Schuth Alexander O.COFO and Secretary | Sale | 17,218 | $284.10K | Form 4 |
| Jan 3, 2026 | Watts Ryan J.President and CEO | Award | 78,960 | — | Form 4 |
| Jan 3, 2026 | Schuth Alexander O.COFO and Secretary | Award | 57,700 | — | Form 4 |
| Nov 4, 2025 | Van Hauwermeiren TimothyDirector | Award | 10,632 | — | Form 4 |
| Sep 3, 2025 | Watts Ryan J.President and CEO | Gift | 50,000 | — | Form 4 |
| Aug 13, 2025 | Ho CaroleChief Medical Officer | Sale | 806 | $11.80K | Form 4 |
| Aug 12, 2025 | Ho CaroleChief Medical Officer | Sale | 2,937 | $39.88K | Form 4 |
| Aug 12, 2025 | Schuth Alexander O.COFO and Secretary | Sale | 2,937 | $39.88K | Form 4 |
| Aug 5, 2025 | Ho CaroleChief Medical Officer | Option exercise | 44,655 | $30.37K | Form 4 |
| Jul 9, 2025 | Watts Ryan J.President and CEO | Sale | 495,282 | $7.43M | Form 4 |
| Jul 9, 2025 | Watts Ryan J.President and CEO | Option exercise | 40,000 | $211.20K | Form 4 |
| Jul 9, 2025 | Watts Ryan J.President and CEO | Option exercise | 455,282 | $309.59K | Form 4 |
| Jun 3, 2025 | Tessier-Lavigne MarcDirector | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | Thornberry NancyDirector | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | Schenkein David PDirector | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | Klein Peter SDirector | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | FLATLEY JAY TDirector | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | Krognes Steve E.Director | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | Cook Jennifer E.Director | Award | 6,037 | — | Form 4 |
| Jun 3, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 10,565 | — | Form 4 |
| Jun 3, 2025 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Award | 10,565 | — | Form 4 |
| Jan 7, 2025 | Krognes Steve E.Director | Sale | 3,339 | $69.48K | Form 4 |
| Jan 7, 2025 | Watts Ryan J.President and CEO | Sale | 7,650 | $159.20K | Form 4 |
| Jan 7, 2025 | Schuth Alexander O.COFO and Secretary | Sale | 2,907 | $60.49K | Form 4 |
| Jan 7, 2025 | Ho CaroleChief Medical Officer | Sale | 2,907 | $60.49K | Form 4 |
| Jan 6, 2025 | Watts Ryan J.President and CEO | Sale | 29,266 | $591.76K | Form 4 |
| Jan 6, 2025 | Schuth Alexander O.COFO and Secretary | Sale | 12,255 | $247.80K | Form 4 |
| Jan 6, 2025 | Ho CaroleChief Medical Officer | Sale | 12,255 | $247.80K | Form 4 |
| Jan 3, 2025 | Schuth Alexander O.COFO and Secretary | Award | 54,180 | — | Form 4 |
| Jan 3, 2025 | Watts Ryan J.President and CEO | Award | 54,180 | — | Form 4 |
| Jan 3, 2025 | Ho CaroleChief Medical Officer | Award | 54,180 | — | Form 4 |
| Dec 31, 2024 | Krognes Steve E.Director | Sale | 30,000 | $607.50K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4